BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac

We evaluated neutralizing antibodies against the Omicron variant and Anti-Spike IgG response in solid organ (SOT) or hematopoietic stem cell (HSTC) recipients after a third dose of BNT162b2 (BNT) or CoronaVac (CV) following two doses of CV. In total, 95 participants underwent SOT (n = 62; 44 liver,...

Descripción completa

Detalles Bibliográficos
Autores principales: Erol, Çiğdem, Kuloğlu, Zeynep Ece, Kayaaslan, Bircan, Esken, Gülen, Altunsoy, Adalet, Barlas, Tayfun, Çınar, Güle, Hasanoğlu, İmran, Oruç, Ebru, İncir, Said, Azap, Alpay, Korkmaz, Gülten, Turan Gökçe, Dilara, Kırımker, Onur Elvan, Coşkun Yenigün, Ezgi, Ölçücüoğlu, Erkan, Ayvazoğlu Soy, Ebru, Çetinkünar, Süleyman, Kurt Azap, Özlem, Can, Füsun, Haberal, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383925/
https://www.ncbi.nlm.nih.gov/pubmed/37515220
http://dx.doi.org/10.3390/v15071534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383925/
https://www.ncbi.nlm.nih.gov/pubmed/37515220
http://dx.doi.org/10.3390/v15071534

Ejemplares similares